A Study Evaluating Aprocitentan Tablets(SYH9108) for the Treatment of Resistant Hypertension

NCT07635914 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Resistant Hypertension

Interventions

DRUG: Aprocitentan tablets(SYH9108)
DRUG: Placebo

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.